Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,105–3,112 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Oculis Holding AG Privosegtor - (PIONEER-1) Acute Optic Neuritis (AON) Phase 3 Trial Planned oral Opthalmic
Oculis Holding AG Licaminlimab (OCS-02) - (PREDICT-1) Dry eye disease Phase 3 Trial Planned Topical ocular Opthalmic
Oculis Holding AG OCS-01 - (DIAMOND-1) Diabetic macular edema (DME) Phase 2/3 Ongoing Topical ophthalmic Opthalmic
Oculis Holding AG OCS-02 Uveitis Phase 2b Trial Planned Topical Opthalmic
Oculis Holding AG OCS-05 - (ACUITY) Acute optic neuritis Phase 2 Data Released Intravenous Opthalmic
Oculis Holding AG OCS-01 - (LEOPARD) Cystoid macular edema Phase 2 Ongoing Ocular Opthalmic
OKYO Pharma Limited urcosimod (OK-101) Dry Eye Disease (DED) Phase 2 Data Released Ocular Opthalmic
OKYO Pharma Limited Urcosimod (OK-101) Neuropathic corneal pain (NCP) Phase 2a Data Released Ocular Opthalmic